Globe Salvage and Vision Preservation by Neoadjuvant Darovasertib and Crizotinib in Uveal Melanoma-Reference-Cited by-同舟云学术

Globe Salvage and Vision Preservation by Neoadjuvant Darovasertib and Crizotinib in Uveal Melanoma

Published:2023-10 Issue: Volume: Page:
ISSN:2468-6530
Container-title:Ophthalmology Retina
language:en
Short-container-title:Ophthalmology Retina

Author:

Hiong Alison^ORCID,O’Day Roderick^ORCID,Fog Lotte S.^ORCID,McKay Daniel^ORCID,McKenzie John,Ameratunga Malaka^ORCID,Joshua Anthony M.^ORCID,Shackleton Mark^ORCID

Funder

Royal Victorian Eye and Ear Hospital

Publisher

Elsevier BV

Subject

Ophthalmology

Reference14 articles.

1. Mutations in GNA11 in uveal melanoma;Van Raamsdonk;N Engl J Med,2010

2. Genomic profiling of metastatic uveal melanoma and clinical results of a phase I study of the protein kinase C inhibitor AEB071;Piperno-Neumann;Mol Cancer Ther,2020

3. Protein kinase C inhibitor AEB071 targets ocular melanoma harboring GNAQ mutations via effects on the PKC/Erk1/2 and PKC/NF-κB pathways;Wu;Mol Cancer Ther,2012

4. Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations;Chen;Oncogene,2014

5. A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma;Piperno-Neumann;Br J Cancer,2023

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Fight Tumour Blindness Registry: Efficient capture of high-quality real-world data in uveal melanoma;Canadian Journal of Ophthalmology;2024-05

2. Personalized ocular oncology care: how far have we come?;Canadian Journal of Ophthalmology;2024-05

3. Identification and validation of a costimulatory molecule-related signature to predict the prognosis for uveal melanoma patients;Scientific Reports;2024-04-21